Home › Compare › LLLI vs JNJ

LLLI vs JNJ: Dividend Comparison 2026

LLLI yields 47158.69% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LLLI wins by $2.6726351763512977e+23M in total portfolio value
10 years
LLLI
LLLI
● Live price
47158.69%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.6726351763512977e+23M
Annual income
$266,153,300,541,234,160,000,000,000,000.00
Full LLLI calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LLLI vs JNJ

📍 LLLI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLLLIJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LLLI + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LLLI pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LLLI
Annual income on $10K today (after 15% tax)
$4,008,488.56/yr
After 10yr DRIP, annual income (after tax)
$226,230,305,460,049,040,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LLLI beats the other by $226,230,305,460,049,040,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LLLI + JNJ for your $10,000?

LLLI: 50%JNJ: 50%
100% JNJ50/50100% LLLI
Portfolio after 10yr
$1.3363175881756489e+23M
Annual income
$133,076,650,270,617,080,000,000,000,000.00/yr
Blended yield
99.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LLLI
No analyst data
Altman Z
-153.9
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LLLI buys
0
JNJ buys
0
No recent congressional trades found for LLLI or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLLLIJNJ
Forward yield47158.69% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$2.6726351763512977e+23M$20.0K ✓
Annual income after 10y$266,153,300,541,234,160,000,000,000,000.00 ✓$827.78
Total dividends collected$2.6719062211588836e+23M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LLLI vs JNJ ($10,000, DRIP)

YearLLLI PortfolioLLLI Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$4,726,569$4,715,868.90$10,676$355.77+$4.72M → LLLI
2$2,088,223,715$2,083,166,286.76$11,407$389.39+$2088.21M → LLLI
3$862,378,453,324$860,144,053,948.76$12,198$426.53+$862378.44M → LLLI
4$332,899,967,545,889$331,977,222,600,832.40$13,056$467.62+$332899967.53M → LLLI
5$120,124,083,810,138,750$119,767,880,844,864,660.00$13,987$513.12+$120124083810.12M → LLLI
6$40,518,446,271,099,530,000$40,389,913,501,422,680,000.00$14,998$563.56+$40518446271099.51M → LLLI
7$12,775,800,667,184,365,000,000$12,732,445,929,674,291,000,000.00$16,098$619.52+$12775800667184366.00M → LLLI
8$3,765,675,090,377,197,000,000,000$3,752,004,983,663,309,700,000,000.00$17,295$681.69+$3765675090377197056.00M → LLLI
9$1,037,586,069,061,300,000,000,000,000$1,033,556,796,714,596,500,000,000,000.00$18,599$750.82+$1.0375860690613e+21M → LLLI
10$267,263,517,635,129,800,000,000,000,000$266,153,300,541,234,160,000,000,000,000.00$20,022$827.78+$2.6726351763512977e+23M → LLLI

LLLI vs JNJ: Complete Analysis 2026

LLLI — Stock

Lamperd Less Lethal, Inc. designs, develops, manufactures, and sells civil and military defense equipment worldwide. The company offers 37/40 mm launchers, hand held revolvers, body warm cameras, crowd control tanks, soft products, and pepper sprays; ammunition products, such as bullets and projectiles; mobile defenders; interlocking shields; and training programs, suites, and mats, as well as firearm training systems. It also provides Flash Grenade, a lightweight, roll-resistant, and re-usable system, which throws a 10 millisecond blinding light; 50 calibur upper shortie; and launching systems. The company was formerly known as Sinewire Networks Inc. and changed its name to Lamperd Less Lethal, Inc. in March 2005. Lamperd Less Lethal, Inc. was founded in 1969 and is based in Sarnia, Canada.

Full LLLI Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LLLI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LLLI vs SCHDLLLI vs JEPILLLI vs OLLLI vs KOLLLI vs MAINLLLI vs ABBVLLLI vs MRKLLLI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.